A Pilot Study Of The Effects Of Microcurrent On Three Sleep Surveys

A Pilot Study Of The Effects Of Microcurrent On Three Sleep Surveys

Participants identified as having primary insomnia will be randomly assigned to groups receiving microcurrent stimulation or sham in a double-blind randomized controlled trial. The microcurrent device used is FDA approved for the treatment of insomnia.

The hypothesis is that the experimental group will have significantly improved scores on three sleep surveys after treatment while the sham group will not.

Inclusion Criteria:

• Student, Faculty or Staff
• Age 18 - 40
• Symptoms of primary insomnia

Exclusion Criteria:

• No implanted electric devices
• No local infection, injury or malignancy
• No history of seizure or other neurological disorders
• No current use of prescription or other substances that could effect sleep quality or quantity
• Pregnancy